Interaction of small ribosomal and transfer RNAs with a protein from Leishmania donovani by Ghosh, Anil et al.
Nucleic Acids Research, 1994, Vol. 22, No. 9 1663 -1669
Interaction of small ribosomal and transfer RNAs with a
protein from Leishmania donovani
Anil Ghosh+, Trina Ghosh, Subhagata Ghosh, Saumitra Das§ and Samit Adhya*
Genetic Engineering Laboratory, Indian Institute of Chemical Biology, 4 Raja S.C. Mullick Road,
Calcutta 700032, India
Received January 11, 1994; Revised and Accepted March 30, 1994
ABSTRACT
Using synthetic antisense RNA from the 5'-untranslated
region of the ,B-tubulin gene as probe in gel retardation
assays, a heat stable RNA-binding factor was identified
in promastigotes of the kinetoplastid protozoan
Leishmania donovani. The same or similar factors
interact with several small ribosomal RNA (srRNA)
species and, more weakly, with tRNA, as shown by
binding and competition experiments. Deletion analysis
indicated involvement of repeated purine-rich motifs on
the antisense RNA, in the reaction. Related, conserved
motifs occur on at least two of the srRNAs. By a
modified Western blot assay, the RNA-binding species
was identified as a single, small polypeptide. The
activity is apparently specific for the promastigote
stage of the parasite, being undetectable in
amastigotes. The properties of this RNA-binding factor
suggest that it is a novel, previously uncharacterised
protein.
INTRODUCTION
The kinetoplastid protozoan Leishmania is characterised by a
dimorphic life-cycle consisting of an intracellular stage
(amastigotes) in the mammalian host and a flagellated stage
(promastigotes) in the gut of sandfly vectors (1). During
differentiation of one stage to the other, the synthesis of a number
of proteins is regulated. For example, tubulin synthesis increases
dramatically within a few hours of amastigote differentiation in
vitro (2,3). Induction of ,B-tubulin synthesis in L.mexicana (4,5)
and L.donovani (3) was previously shown to be regulated at the
post-transcriptional level. Superimposed upon this specific genetic
regulation are a number of global changes in amastigote
metabolism, e.g., cellular and mitochondrial enlargement (6- 8),
increased respiration rate (9), and enhanced overall rates of
protein synthesis (3). Regulation of translation may occur through
the interaction of protein or nucleoprotein factors with the
translation machinery, but whether the effect is specific or global
EMBL accession no. X51821
would depend on the nature of the target (specific mRNAs, all
mRNAs, ribosomes, translation factors, etc.) for the controlling
factor.
Leishmania and other kinetoplastid organisms have a number
of unique features in their translation machinery which set them
apart from other eukaryotes. Cytoplasmic mRNAs contain a
universal 5'-spliced leader sequence (reviewed in ref. 10) with
a hypermodified cap structure (11). Secondly, the 28S rRNA is
split into a number of fragments by processing; two large species,
28Sx and 28S3, of 1.9 and 1.8 kb, and several small ribosomal
RNAs (srRNAs) including 5.8S RNA, and 220 nt, 180 nt, 140
nt, and 70 nt species (12-15). The srRNAs are apparently
associated with polysomes (12), and the 180 nt and 140 nt species
have predicted secondary structure resembling parts of domain
VII of 28S rRNA from other eukaryotes (16). The reason for
this elaborate 'ribosome-in-parts' is unknown. A third remarkable
property is the apparent lack of mitochondrially-encoded tRNA
genes (17) and the sharing of tRNAs between the mitochondrial
and cytoplasmic compartments (17,18), leading to the hypothesis
that mitochondrial tRNAs are imported from the cytoplasm. It
is clear that studies of these small RNAs in Leishmania will lead
to a better understanding of the unique aspects of translation
regulation.
In this report we describe the identification and partial
characterization of a factor in Leishmania promastigotes which
binds with fidelity to a number of srRNAs as well as tRNA. The
activity is detectable in the promastigote but not in the amastigote
stage of the parasite.
MATERIALS AND METHODS
Leishmania strains
Promastigotes of L.donovani strains UR6 and AG83 were
cultured on blood-agar media (19) and medium 199 (GIBCO)
with 10% fetal calf serum, respectively. Strain AG83 was also
passaged in BALB/c mice; amastigotes were isolated from
infected spleens or livers by Percoll gradient centrifugation (3).
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Figure 1. Nucleotide sequence of the 5'-upstream region of the L.donovani 0-tubulin gene (EMBL data Library accession number X 51821). The N-terminal ATG
starts at position +1. The arrow between nucleotides -70 and -71 designates the 3'-acceptor site for trans-splicing of the universal mini-exon (30). Below the
sequence, the leftward end-points of various deletion clones are indicated (except pSG3A, which maps to - 104); all inserts terminate at +25. Bracketed sequences
on the antisense strand denote hexapurine repeats apparently involved in factor-binding (see text).
DNA clones
All DNA clones were derived from subclone jTl-J (S.D and
S.A., unpublished) containing the first 25 bp of the L.donovani
f-tubulin gene and about 240 bp of 5'-upstream sequence.
Unidirectional deletions from the 5 '-upstream end were
constructed using exonuclease Im or nuclease BAL3 1, followed
by linker-ligation and subcloning into polylinker regions of the
dual transcriptional vectors pGEM3Zf(+) (Promega) and pSPTl9
(Boehringer-Mannheim), according to standard procedures (20).
DNA sequences of the inserts were determined by the dideoxy
chain termination method (21).
Preparation of RNA probes
32P-labelled sense or antisense probes were synthesized from the
deletion clones as template using the appropriate phage RNA
polymerase. EcoRI- or HindHI-linearized DNA (0.5 ug) was
incubated in 10 /d of 40 mM Tris-HCI, pH 7.5, 6 mM
MgAc2, 10 mM DTT, 1 mM spermidine, 0.5 mM each of
ATP, GTP and CTP, 10 yM UTP including 104-105 cpm/pmol
of [ct-32p] UTP (Amersham or BARC, Bombay), 100 units/ml
pancreatic RNase inhibitor and 500 units/ml ofRNA polymerase,
for 1 h at 37°. RNA was recovered by ethanol precipitation from
2.5 M NH4Ac at -20°. For competition assays, low-specific
activity RNA was prepared identically except that input
radioactivity was reduced 10-fold and UTP concentration raised
to 0.5 mM.
Labelling of tRNA and small ribosomal RNAs was performed
by dephosphorylation of total or poly A- RNA from
promastigotes with calf intestinal phosphatase, followed by T4
polynucleotide kinase reaction with ['y-32P] ATP (BARC), as
described (20). Individual RNA species were separated on a
denaturing gel for subsequent elution and ethanol precipitation.
Radiolabelled nuclear run-on RNA was prepared using crude
promastigote nuclei as previously described (3).
Preparation of soluble extracts
Leishmania promastigotes or Percoll-purified amastigotes were
washed with phosphate-buffered saline at 40 and lysed with 5
cell volumes of 50mM Tris-HCl, pH 7.5, 0.3 M KCI, 0.2 mM
EDTA, 1 mM DTT, 0.5 mM PMSF, 20% glycerol and 0.1%
Triton X-100 for 5 min on ice. Nuclei, kinetoplasts and cell-debris
were removed by low-speed centrifugation to yeild the cytosol
fraction, which was further centrifuged at 100,000xg for 1 h.
The post-ribosomal supernatant (S-100) was dialysed against 20
mM Tris-HCl, pH 7.5, 0.1 M KCl, 0.2 mM EDTA, 20%
glycerol, 1 mM DTT and 0.5 mM PMSF for 4-6 h at 40 and
stored in aliquots at -70°.
Figure 2. Binding of a heat-stable protein factor(s) to the Leishmania (3-tubulin
antisense RNA. a, 32P-labelled clone pSG3B sense or antisense RNA (2 fmol)
was incubated with the following amounts (as total protein) of a L.donovani strain
UR6 promastigote S-100 extract: lanes 1,8, none; lanes 2,9, 0.017 jig; lanes 3,10,
0.035 ,ug; lanes 4,11, 0.175 Ag; lanes 5,12, 0.35 jg; lanes 6,13, 1.75 ug; lanes
7,14, 3.5 y b, 32P-labelled pSG3B antisense RNA was incubated with an S-100
extract (1.75 isg protein) that has been pre-treated as follows: lane 1, heat-treated
(60°, 5 min) followed by centrifugal clarification; lane 2, proteinase K (2.5 mg/ml);
lane 3, micrococcal nuclease (100 units/ml, 15 min at room temperature) plus
Ca2+ (1 mM), followed by EGTA (2 mM); lane 4, EGTA added before Ca2+
and micrococcal nuclease. Heparin-resistant complexes were assayed by gel
retardation as described in Materials and Methods.
Gel retardation assay
Binding assays (10 jil) contained binding buffer (10 mM
Tris-HCl, pH 7.5, 5 mM MgAc2, 2 mM DTT), 32P-labelled
RNA and cytosol or S-100 extract as indicated. After incubation
for 30 min at 00, heparin was added to 5 mg/ml and incubation
continued for a further 10 min. Samples were electrophoresed
on a native 5% polyacrylamide gel (acrylamide:bis-acrylamide
= 60:1) in 50 mM Tris-borate, 1 mM EDTA, pH 8.3 at 8 V/cm
for 2-3 h before autoradiography.
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Figure 4. Competition assays. a, 32P-labelled pSG3B antisense RNA (2 fmol)
was incubated with 0.175 Ag of heated S-100 extract in presence of 0, 20, 20,
60, 100 and 200 fmol (anes 2-7) of low-specific activity pSG3B antisense RNA;
b, 32P-tRNA (8000 cpm) incubated with 0.75 izg of heat-treated S-100 extract
in presence of 3, 15, 30, and 150 ng Oanes 3-6) of pSG3B antisense RNA;
c, d, 32P-140 nt srRNA (8000 cpm) was incubated with 1.5 isg S-100 extract
in presence of 10, 20, 50, and 100 ng of pSG3B antisense RNA (lanes 3-6 of
panel c) or 10, 20, 50, 100 and 500 ng of poly A (lanes 1-6, panel d). Activity
was assayed by gel retardation as before.
Figure 3. Binding of Leishrania factor(s) to ribosomal RNAs and tRNA. a,
the following RNAs and DNAs were incubated without (-) or with (+) a
promastigote S-100 extract: lanes 1,2, sense-strand RNA from clone fiT-H (S.D.
and S.A., unpublished) containing C-terminal and 3-downstream regions of the
L.donovani 4-tubulin gene; lanes 3,4, sense-strand RNA from a L.donovani med
RNA clone (30); lanes 5,6, linear double-stranded pSG3B DNA, 3'-end labelled
on the antisense strand; lanes 7,8, the same DNA, heat-denatured; lanes 9,10,
pSG3B sense-antisense RNA hybrid. b, poly A- RNA from promastigotes was
5,_32p labelled and electrophoresed on a denaturing 6% polyacrylamide gel (lane
2) alongside molecular weight markers (lane 1); individual bands/regions were
excised, the RNAs eluted and 7000 cpm were incubated with (+) or without
(-) a 600-treated S-100 extract (3 itg). Lanes 3,4, 30-60 nt RNA; lanes 5,6,
tRNA; lanes 7,8, 120 nt (5S) RNA; lanes 9,10, 140 nt srRNA; lanes 11,12,
a mixture of 180 nt srRNA and 190 nt (5.8S) srRNA; and lanes 13,14, 220 nt
srRNA. c, 32P-labelled tRNA (8000 cpm) was incubated with increasing amounts
of a 60°-treated S-100 extract: lane 1, none; lanes 2-8, 0.1, 0.2, 0.4, 0.6, 1,
2 and 4 og of extract.
Northwestern blotting
Total proten of cytosolic or S-100 extracts was electrophoresed
on an SDS-12.5% polyacrylamide gel (22) and electro-blotted
on nitrocellulose (23) for 18 h at room temperature. The filter
was washed 4 times with 0.1 M Tris-HCI, pH 7.5, 0.1% NP40,
each for 30 min at 40 with gentle agitation, then blocked with
binding buffer (see previous section) containing 5% BSA and
0.01% Triton X-100 for 5 min. The blocked filter was incubated
with 105- 106 cpm/ml of 32P-labelled RNA probe in binding
buffer containing 0.01% Triton X-100 for 18 h at 40 with gentle
agitation. The filter was washed 3 times for 5 min each with
binding buffer, then autoradiographed.
RESULTS
Binding of synthetic (3-tubuiin antisense RNA with a protein
factor(s) in Leishmania extracts
Post-ribosomal supernatants from detergent-lysed Leishmania
promastigotes were incubated with 32P-labelled transcripts of the
Leishmania donovani 3-tubulin 5'-upstream region (Fig. 1), and
then assayed by the gel retardation technique. No RNA-protein
complexes with the plus strand were observed under the
conditions of the assay (Fig. 2A). However, in a control
experiment with the corresponding antisense strand, stable,
specific heparin-resistant RNA -protein complexes were detected
(Fig. 2a). Titration of extract resulted in progressive retardation
of the complex, to a saturation level (Fig 2a). This 'step-profile'
is characteristic of binding of other RNA ligands (see below),
and indicates interaction of multiple molecules of factor with each
molecule of RNA.
Figure 2b shows that (1) the factor is heat-stable (up to about
600), (2) activity is sensitive to protease, and (3) there is
apparently no micrococcal nuclease-sensitive component. Thus
the active component is a heat-stable protein. Re-extraction and
electrophoresis of the complexed RNA demonstrated that gel-
retardation was not due to an irreversible covalent modification
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Figure 5. Northwestern blot analysis of RNA-binding factor. Western blots of
heated S-100 extracts (60 ztg protein) were incubated with the following 32P-
labelled RNA probes, as described in Materials and Methods: lane 1, pSG3B
antisense RNA; lane 2, nuclear RNA; lane 3, L.donovani tRNA; lane 4, yeast
tRNA. Arrowheads show the 15-kDa band (lanes 1, 2 and 5, 6 were from different
gels (12% and 10% polyacrylamide, respectively; thus the band has migrated
differently). RNA in the band in lane 2 was eluted, electrophoresed on a denaturing
5% acrylamide gel and autoradiographed; lane 5, eluted RNA; lane 6, yeast tRNA
marker.
mediated by a protein factor. Complex formation occured in
presence of K+ concentrations of up to 1 M, and was not
dependent on Mg2+ (data not shown).
Specific binding of tRNA and small ribosomal RNAs
To check sequence-specificity of binding, a number of labelled
RNAs and DNAs were incubated with a heated S-100 extract.
Synthetic RNAs from the (3-tubulin C-terminal region and a
cloned med RNA gene did not form detectable complexes
(Fig.3a). Double-stranded or denatured DNA, or sense-
antisense RNA hybrids, were similarly unaffected (Fig.3a). Thus
the binding factor is specific for single-stranded RNA.
Next, total or poly A- RNA from Leishmania promastigotes
was 5'-32P-labelled with polynucleotide kinase and the small
labelled RNA species isolated after polyacrylamide gel
electrophoresis. Several abundant small RNA species were
labelled by this protocol (Fig. 3b), including tRNA, 5S RNA
and the 220, 180, 140, and 70 nt small ribosomal RNAs
(srRNAs) previously identified in kinetoplastid organisms
(12-16). When incubated with S-100 extracts, all RNAs, with
the exception ofRNA in the 30-60 nt region, showed complex
formation (Fig. 3b). With tRNA or 5S RNA, a smear rather than
a specific band was observed at this extract concentration. Extract
titration experiments with labelled tRNA (Fig. 3c) and the 140
nt srRNA (not shown) revealed the same 'step-profile' seen with
antisense RNA (Fig. 2). Yeast tRNA showed similar binding
activity (data not shown). It is to be noted, however, that detection
of these complexes requires higher extract concentrations than
the antisense RNA reaction (compare Figs. 2 and 3) and that
while all batches of extract exhibit antisense binding activity,
some do not demonstrably bind tRNA. This argues for either
(1) a lower affinity of the same factor for srRNAs compared to
Figure 6. Factor-binding activity of antisense RNA deletion clones: Gel retardation
assay. 32P-labelled antisense RNA (2 fmol) from clones pSG3B (panel a), pSG3Y
(panel b), pSG3Q (panel c), pSG3P (panel d) and pSG3S (panel e) was incubated
with the following dilutions of a 60°-treated promastigote extract (2 mg/ml original
protein concentration; same batch of extract used in all cases): none, 1 Ul each
of 128, 64, 32, 16, 8, 4, and 2-fold dilutions, and 1 and 2 "I of undiluted extract
(lanes 1-10 respectively). For each clone, the deletion-endpoint and titre, i.e.,
the lowest dilution at which no band-retardation was observed, are indicated on
the right.
antisense RNA, or (2) different factors binding to the different
RNAs.
Competition assays to determine binding specificity of
different RNAs
To determine whether the same, similar or different factors binds
to antisense RNA and other RNAs, competition assays were
performed. Binding to labelled antisense RNA, tRNA and the
140 nt srRNA were effectively competed by excess low-specific
activity antisense RNA (Fig. 4a, b and c), but not by poly A
(Fig. 4d), poly U, poly C or an antisense DNA oligonucleotide
spanning positions -22 to -38 (see Fig. 1) of the ,3-tubulin
5 '-upstream region (data not shown). These results indicate that
the same or similar factors interacts with all three types of RNA,
and that the binding is sequence-specific (otherwise the synthetic
polynucleotide would compete). However, tRNA was a poor
competitor of antisense RNA binding (data not shown), probably
reflecting the much lower affinity of tRNA -protein interaction.
Binding of labelled RNAs to factors immobilised on
nitrocellulose: the 'Northwestern' blot
To obtain information on the subunit composition of the RNA-
binding factor, an S-100 extract from Leishmania promastigotes
was electrophoresed on an SDS-polyacrylamide gel, and
a
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Figure 7. Deletion analysis of antisense RNA: Northwestern blot. Western blot
strips of S-100 extract (50 yg) were incubated with 106 cpm/ml of the following
32P-labelled RNAs: lane 1, clone pSG3B sense(S); lane 2, clone pSG3B antisense
(AS); lane 3, clone pSG3P antisense; lane 4, clone pSG3S antisense. The
arrowhead shows the 15. 1-kDa band. The apparent doublet in lane 3 is a gel
artifact.
'Western' blotted to nitrocellulose. After sequential renaturing
and blocking steps, the filter was incubated with 32P-labelled
RNA probe. Following washing and autoradiography, a single
band of molecular weight approximately 15 kDa was observed
with the 3-tubulin antisense RNA probe (Fig. 5). In control
experiments, (1) no band was observed with the corresponding
sense strand as probe (Fig. 7), and (2) the binding activity was
resistant to prior heat-treatment of the extract. Labelled tRNA
was bound to an identical-sized band (Fig. 5). These results are
consistent with the hypothesis that j-tubulin antisense RNA, and
tRNA (as well as, possibly, the srRNAs) recognize similar or
identical protein species.
One application of the Northwestern technique is the selection
of specific RNA ligands from a heterogenous RNA probe. We
searched for a physiologically relevant RNA ligand by using
32P-labelled promastigote nuclear run-on RNA to probe a
Western blot. Again, the 15-kDa band was observed (Fig. 5).
RNA bound to the filter was eluted, concentrated and run on
a denaturing polyacrylamide gel; a broad band was observed
which roughly comigrated with tRNA (Fig. 5).
Extracts from rat liver and E. coli, when similarly blotted, did
not react with f-tubulin antisense RNA (data not shown). The
activity therefore appears to be cell-specific or stage-specific (see
below).
Deletion analysis of the factor-binding site in the f-tubulin
5'-upstream antisense region
Unidirectional deletions were constructed within the 3-tubulin
5'-upstream region (Fig. 1). Titration of extract showed that all
the deletions mapping between -53 and -20 bound factor, but
apparently with different affinities (Fig. 6). A clone mapping to
about + 1 was inactive (data not shown). To compare activities
of different clones, serial dilutions of extract were incubated with
RNA and the end-point or titre, i.e., lowest dilution at which
no complex is observed, determined. It was reasoned that the
higher the end-point for a particular clone, the greater would be
the affinity of RNA -protein complex formation.
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Figure 8. RNA binding activity in different stages of the L.donovani life-cycle.
a, Gel retardation assay. 32P-labelled pSG3A antisense RNA (2 fmol) was
incubated with heat-treated cytosolic extract as follows: lane 1, none; lanes 2-7,
0.034, 0.068, 0.136, 0.272, 0.544 and 1.09 ytg of protein, respectively, of
amastigote extract; lanes 8, 9, 0.5 and 0.125 jg of promastigote extract; lane
10, 0.25 ytg of promastigote plus 0.27 ztg of amastigote extract; lane 11, 0.25
ytg of promastigote plus 0.068 sg of amastigote extract. b, Northwestern blot.
Total protein (65 Ag) of an S-100 extract from Ldonowvni strain UR6 promastigotes
(lane 1), cytosol from L.donovani strain AG83 promastigotes (lane 2) and cytosol
from L.donovawi strain AG83 amastigotes Oane 3) was Western blotted and probed
with pSG3B antisense RNA probe (106 cpm/ml). Sizes (in kDa) of protein
standards are indicated on the left.
Figure 6 shows that, as nucleotides were progressively deleted
from -53 to -20, there was a stepwise loss of activity reflected
by lower titres. Deletion of 26 nucleotides (between -53 to -27)
reduced the titre about 4-fold. Between -27 and -20, there was
a further 4-8 fold drop in titre (Fig. 6).
The order of affinities pSG3B (mapping to -53) > pSG3P
(-27) > pSG3S (-20) was confirmed by two other experiments.
1) Cross-competition assays showed that pSG3B RNA was more
effective in competing with labelled pSG3P RNA than with itself
(data not shown). 2) Western blot strips of S-100 extracts were
incubated with equivalent amounts of pSG3B, pSG3P and pSG3S
RNA. A strong 15. 1-kDa band was observed with pSG3B, a
weaker band with pSG3P and no band with pSG3S (Fig. 7).
Examination of the antisense sequence in this region revealed
the presence of repeated purine-rich motifs (Fig. 1). Between
-13 and -27 there are two overlapping repeats ofGGCGAAA
A/G G. A part of this motif, GAAAGG, is repeated a third time
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between -27 to -32. Clones mapping at -53, -31 and -20
contain, respectively, 3, 2 and 1 intact copies of the hexapurine
motif, roughly correlating with their relative activities.
RNA binding activity at different stages of the Leishmania
life cycle
The above experiments were performed with extracts from the
flagellated, promastigote form of the parasite. To assess the role,
if any, of the factor in differentiation, cytosolic extracts from
purified amastigotes (the intracellular form present in mammalian
hosts) were assayed for RNA binding activity by gel retardation.
Titration of amastigote extract failed to show activity (Fig. 8a).
Mixing experiments with active promastigote extracts showed
that this lack of activity was not due to presence of proteases
or inhibitors in the amastigote extracts (Fig. 8a).
One problem with the solution assay is the presence of nuclease
activity in the amastigote preparations (leading to partial probe
degradation; Fig. 8a). This problem could be circumvented by
the blot assay, since SDS-PAGE would presumably separate
nucleases from the factor. As shown in Fig. 8b, the 15-kDa band
was observed using promastigote but not amastigote extracts.
DISCUSSION
A combination of gel retardation assays, competition experiments
and blotting techniques was used to demonstrate a heat-stable
factor(s) in Leishmania promastigotes that specifically interacts
with a population of functionally related small RNAs: the srRNAs
and tRNA. Specificity was judged by a number of criteria: (1)
formation of discrete complexes resistant to heparin, DNA,
synthetic polynucleotides and high salt concentrations; (2) absence
of detectable binding to single- or double-stranded DNA, double-
stranded RNA or other single-stranded RNAs. Therefore in terms
of specificity the factor lies somewhere between non-specific
histones, single-strand binding proteins, etc., and the highly
specific translational regulators which interact with single
mRNAs.
The role of specific regions of the 3-tubulin antisense RNA
in the binding reaction was investigated by deletion mutagenesis.
The apparent affinity of binding was reduced as the purine-rich
motifs CGAAAGG, CGAAAAG and AAAGGG were
progressively deleted (Figs. 1, 6 and 7). Thus, these and similar
motifs may constitute part or whole of the binding site. The
proximity of these motifs to each other (Fig. 1) suggests
cooperativity in the antisense RNA-factor interaction.
Competition experiments indicated that the antisense RNA,
srRNAs and tRNA share recognition motifs for the Leishmania
factor (Fig. 4). Hence, a computer-aided search of the highly
conserved 180 nt, 140 nt and 70 nt srRNA sequences of
trypanosomes (16) and crithidia (24) for the above purine-rich
motifs were conducted. Two observations were made: (1) The
homologous sequences GAAGGG, CGAGAGG and CGAAGGG
occur at positions 11, 53 and 96 respectively of the 180 nt srRNA.
The 140 nt srRNA contains the motifCGAGAG at position 18.
The 70 nt srRNA does not contain a similar motif. (2) All of
these motifs lie within hairpin-loop regions of the predicted
secondary structures (16). The CGAGAGG motif on the 180 nt
srRNA is part of a highly conserved sequence on 28S rRNA in
other eukaryotes that acts as a cleavage site for ct-sarcin (25)
and constitutes part of the ribosomal A-site. The sequence of
been published, but a survey of 5S RNA sequences from other
sources revealed the conserved sequence YGGGAA at the
junction of helix E and loop d' of the secondary structure (26).
The binding site on tRNA is not easily recognizable at the primary
sequence level, since only a few residues are universally
conserved (27). The relatively purine-rich D-loop is one
possibility. The factor may discern a conserved secondary or
tertiary structure motif on tRNA rather than a primary sequence.
The Leishmania RNA binding factor was originally detected
by complex formation with RNA polymerase-generated in vitro
transcripts. This led to the speculation that regulation of 0-tubulin
synthesis during differentiation is mediated by antisense RNA
and its cognate factor. Such a possibility was rendered unlikely
by three observations: (1) No antisense RNA derived from the
,B-tubulin 5 '-untranslated region was detectable by RNase
mapping of total cellular RNA (M.Bhaumik and S.A.,
unpublished data). (2) Transcription of tubulin genes in
Leishmania (28) and Crithidia (29) is strand-asymmetric. (3)
During amastigote-to-promastigote differentiation tubulin
synthesis is induced earlier (at 1-4 h; ref.3) than the RNA
binding activity (at about 24 h; data not shown). It may be argued,
therefore, that the antisense RNA fortuitously possesses sequences
that act as strong binding sites for the factor, and that the true
physiological ligand is some other cellular RNA, such as tRNA
or srRNA. Binding-selection of nuclear RNA showed that the
RNA ligand(s) is indeed present in vivo (Fig.5). The identity of
this RNA, which migrates in the tRNA region of the gel, remains
unknown pending sequence analysis.
Although f-tubulin antisense RNA is a non-physiological
ligand, it targets a single protein species in Leishmania (Fig.5),
and is capable of competing with srRNAs and other ligands for
binding to the factor (Fig.4). These facts may be exploited to
determine the location and function of the RNA binding protein
by in vivo and in vitro targetting experiments.
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